Autolus Therapeutics plc - American Depositary Share (AUTL) Social Stream



Autolus Therapeutics plc - American Depositary Share (AUTL): $2.64

0.13 (+5.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AUTL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

Featured Post From StockTwits About AUTL

$AUTL Summary why I am long and I do not care when they put the price down like yesterday:
1. Better Tech. The key differentiating feature of Autolus' CAT is that fact that it has a very fast off-rate that is at least 100 times faster than competitor CD19 binders (Figure 2). This means that AUTO1 CAR-T cells are able to kill target cancer cells by contacting them for a much shorter period of time, as a normal T-cell would.
2. Orphan Drug FDA designation + PIM designation
3. Lizenz Agreement with Moderna
4. Great promising early result. 100% complete remission
5. Enough funding
6. New partnership any time possible
7. Early buyout in 2022 possible
8. Still flying under the radar
9. Expecting more institutional investors coming in
10. Expecting further great data EOY and in 2022

Feel free to add this list. IMO
Reminder from 2020: https://seekingalpha.com/article/4346557-autolus-highly-undervalued-car-t-company
LuigiMoro, published August 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5088 seconds.